| IXC Stock | | | 0.07 0.01 7.46% |
Invex Therapeutics financial indicator trend analysis is infinitely more than just investigating Invex Therapeutics recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Invex Therapeutics is a good investment. Please check the relationship between Invex Therapeutics Net Income and its Gross Profit accounts. Check out
Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Invex Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in board of governors.
Net Income vs Gross Profit
Net Income vs Gross Profit Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Invex Therapeutics Net Income account and
Gross Profit. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between Invex Therapeutics' Net Income and Gross Profit is -0.33. Overlapping area represents the amount of variation of Net Income that can explain the historical movement of Gross Profit in the same time period over historical financial statements of Invex Therapeutics, assuming nothing else is changed. The correlation between historical values of Invex Therapeutics' Net Income and Gross Profit is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Income of Invex Therapeutics are associated (or correlated) with its Gross Profit. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Gross Profit has no effect on the direction of Net Income i.e., Invex Therapeutics' Net Income and Gross Profit go up and down completely randomly.
Correlation Coefficient | -0.33 |
| Relationship Direction | Negative |
| Relationship Strength | Insignificant |
Net Income
Net income is one of the most important fundamental items in finance. It plays a large role in Invex Therapeutics financial statement analysis. It represents the amount of money remaining after all of Invex Therapeutics operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.
Gross Profit
Gross profit is a required income statement account that reflects total revenue of Invex Therapeutics minus its cost of goods sold. It is profit before Invex Therapeutics operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.
Most indicators from Invex Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Invex Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Invex Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in board of governors.
Issuance Of Capital Stock is likely to gain to about 10
M in 2024, whereas
Selling General Administrative is likely to drop slightly above 1.1
M in 2024.
| 2022 | 2023 | 2024 (projected) |
Gross Profit | 459.1K | 1.2M | 1.3M | Total Revenue | 459.1K | 1.2M | 1.3M |
Invex Therapeutics fundamental ratios Correlations
Click cells to compare fundamentals
Invex Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Invex Therapeutics fundamental ratios Accounts
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Additional Tools for Invex Stock Analysis
When running Invex Therapeutics' price analysis, check to
measure Invex Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Invex Therapeutics is operating at the current time. Most of Invex Therapeutics' value examination focuses on studying past and present price action to
predict the probability of Invex Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Invex Therapeutics' price. Additionally, you may evaluate how the addition of Invex Therapeutics to your portfolios can decrease your overall portfolio volatility.